Endothelin levels in experimental diabetes combined with cardiac hypertrophy

R. Skoumal, Leila Seres, P. Soós, Èva Balogh, Tìmea Kovàts, Jaana Rysa, Heikki Ruskoaho, Miklós Tóth, F. Horkay

Research output: Contribution to journalArticle

Abstract

Diabetes mellitus is associated with endothelial and cardiac dysfunction, and endothelin has been suggested to alter cardiac function by being a positive inotropic agent, modulating the Frank-Starling response, contracting the coronary arteries and inducing tissue proliferation. We investigated endothelin levels in diabetic and in healthy dogs, 1 and 3 days after placing arteriovenous shunts (8 weeks after diabetes induction) in the femoral regions. Right and left ventricular weight/body weight ratios and N-terminal-atrial natriuretic peptide were increased in shunted animals (P <0.05). Plasma endothelin levels were comparable in healthy and diabetic dogs. Shunted circulation did not change systemic endothelin levels in healthy dogs but reduced endothelin levels in diabetic dogs. The functional significance of altered endothelin responses to acute hemodynamic burden in experimental diabetes needs further investigation.

Original languageEnglish
JournalJournal of Cardiovascular Pharmacology
Volume44
Issue numberSUPPL. 1
DOIs
Publication statusPublished - Nov 2004

Fingerprint

Endothelins
Cardiomegaly
Dogs
Starlings
Atrial Natriuretic Factor
Thigh
Coronary Vessels
Diabetes Mellitus
Hemodynamics
Body Weight
Weights and Measures

Keywords

  • Cardiac hypertrophy
  • Diabetes
  • Endothelin

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Endothelin levels in experimental diabetes combined with cardiac hypertrophy. / Skoumal, R.; Seres, Leila; Soós, P.; Balogh, Èva; Kovàts, Tìmea; Rysa, Jaana; Ruskoaho, Heikki; Tóth, Miklós; Horkay, F.

In: Journal of Cardiovascular Pharmacology, Vol. 44, No. SUPPL. 1, 11.2004.

Research output: Contribution to journalArticle

Skoumal, R. ; Seres, Leila ; Soós, P. ; Balogh, Èva ; Kovàts, Tìmea ; Rysa, Jaana ; Ruskoaho, Heikki ; Tóth, Miklós ; Horkay, F. / Endothelin levels in experimental diabetes combined with cardiac hypertrophy. In: Journal of Cardiovascular Pharmacology. 2004 ; Vol. 44, No. SUPPL. 1.
@article{e0cb9b042c9943839a85a8e475f58468,
title = "Endothelin levels in experimental diabetes combined with cardiac hypertrophy",
abstract = "Diabetes mellitus is associated with endothelial and cardiac dysfunction, and endothelin has been suggested to alter cardiac function by being a positive inotropic agent, modulating the Frank-Starling response, contracting the coronary arteries and inducing tissue proliferation. We investigated endothelin levels in diabetic and in healthy dogs, 1 and 3 days after placing arteriovenous shunts (8 weeks after diabetes induction) in the femoral regions. Right and left ventricular weight/body weight ratios and N-terminal-atrial natriuretic peptide were increased in shunted animals (P <0.05). Plasma endothelin levels were comparable in healthy and diabetic dogs. Shunted circulation did not change systemic endothelin levels in healthy dogs but reduced endothelin levels in diabetic dogs. The functional significance of altered endothelin responses to acute hemodynamic burden in experimental diabetes needs further investigation.",
keywords = "Cardiac hypertrophy, Diabetes, Endothelin",
author = "R. Skoumal and Leila Seres and P. So{\'o}s and {\`E}va Balogh and T{\`i}mea Kov{\`a}ts and Jaana Rysa and Heikki Ruskoaho and Mikl{\'o}s T{\'o}th and F. Horkay",
year = "2004",
month = "11",
doi = "10.1097/01.fjc.0000166240.41830.04",
language = "English",
volume = "44",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Endothelin levels in experimental diabetes combined with cardiac hypertrophy

AU - Skoumal, R.

AU - Seres, Leila

AU - Soós, P.

AU - Balogh, Èva

AU - Kovàts, Tìmea

AU - Rysa, Jaana

AU - Ruskoaho, Heikki

AU - Tóth, Miklós

AU - Horkay, F.

PY - 2004/11

Y1 - 2004/11

N2 - Diabetes mellitus is associated with endothelial and cardiac dysfunction, and endothelin has been suggested to alter cardiac function by being a positive inotropic agent, modulating the Frank-Starling response, contracting the coronary arteries and inducing tissue proliferation. We investigated endothelin levels in diabetic and in healthy dogs, 1 and 3 days after placing arteriovenous shunts (8 weeks after diabetes induction) in the femoral regions. Right and left ventricular weight/body weight ratios and N-terminal-atrial natriuretic peptide were increased in shunted animals (P <0.05). Plasma endothelin levels were comparable in healthy and diabetic dogs. Shunted circulation did not change systemic endothelin levels in healthy dogs but reduced endothelin levels in diabetic dogs. The functional significance of altered endothelin responses to acute hemodynamic burden in experimental diabetes needs further investigation.

AB - Diabetes mellitus is associated with endothelial and cardiac dysfunction, and endothelin has been suggested to alter cardiac function by being a positive inotropic agent, modulating the Frank-Starling response, contracting the coronary arteries and inducing tissue proliferation. We investigated endothelin levels in diabetic and in healthy dogs, 1 and 3 days after placing arteriovenous shunts (8 weeks after diabetes induction) in the femoral regions. Right and left ventricular weight/body weight ratios and N-terminal-atrial natriuretic peptide were increased in shunted animals (P <0.05). Plasma endothelin levels were comparable in healthy and diabetic dogs. Shunted circulation did not change systemic endothelin levels in healthy dogs but reduced endothelin levels in diabetic dogs. The functional significance of altered endothelin responses to acute hemodynamic burden in experimental diabetes needs further investigation.

KW - Cardiac hypertrophy

KW - Diabetes

KW - Endothelin

UR - http://www.scopus.com/inward/record.url?scp=11144336070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144336070&partnerID=8YFLogxK

U2 - 10.1097/01.fjc.0000166240.41830.04

DO - 10.1097/01.fjc.0000166240.41830.04

M3 - Article

C2 - 15838277

AN - SCOPUS:11144336070

VL - 44

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - SUPPL. 1

ER -